CHRONIC PULMONARY ASPERGILLOSIS
Clinical trials for CHRONIC PULMONARY ASPERGILLOSIS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC PULMONARY ASPERGILLOSIS trials appear
Sign up with your email to follow new studies for CHRONIC PULMONARY ASPERGILLOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare lung infection: weekly drug shows promise in early trial
Disease control OngoingThis study tests a drug called rezafungin for people with a long-term lung infection caused by a fungus (chronic pulmonary aspergillosis) who have few other treatment choices. About 60 adults will receive the drug once a week for 6 months. Researchers will check if the treatment …
Matched conditions: CHRONIC PULMONARY ASPERGILLOSIS
Phase: PHASE2 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Vitamin D's hidden role in TB and fungal lung disease revealed
Knowledge-focused OngoingThis study looks at whether vitamin D levels are linked to certain immune markers in people with active tuberculosis (TB), with or without a chronic fungal lung infection called aspergillosis. Researchers will compare blood samples from 300 adults—including healthy volunteers—to …
Matched conditions: CHRONIC PULMONARY ASPERGILLOSIS
Sponsor: Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC